Dapaah Michael MD is categorized under Internal Medicine Doctors in Orlando, FL and active since 1993.
Dapaah Michael MD was established in 1993, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Internal Medicine Doctors business, which does work in the B2C market, and is classified as a Internal Medicine Doctors, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Michael Dapaah at the company’s single location by writing to 506 South Chickasaw Trail # 200, Orlando, Florida FL 32825 or by phoning (407) 282-9390. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Dapaah Michael MD |
| Contact Person: | Michael Dapaah |
| Address: | 506 South Chickasaw Trail # 200, Orlando, Florida 32825 |
| Phone Number: | (407) 282-9390 |
| Website Address: | mkdapaah.com |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 1993 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Internal Medicine Doctors |
| SIC Code: | 8011 |
| NAICS Code: | 6211110 |
| Share This Business: |
Dapaah Michael MD was started in 1993 to provide professional Internal Medicine Doctors under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Michael Dapaah for inquiries that concern Dapaah Michael MD by calling the company number (407) 282-9390, as your correspondence is most welcome. Additionally, the physical location of the single location of Dapaah Michael MD can be found at the coordinates 28.53758,-81.2755 as well as the street address 506 South Chickasaw Trail # 200 in Orlando, Florida 32825.
For its online presence, you may visit Dapaah Michael MD’s website at mkdapaah.com and engage with its social media outlets through on Twitter and on Facebook.